DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Wealth First Portfolio Managers Limited — Issue of Securities

NSE 1 hr ago·26 Oct 2026, 6:42 am

Wealth First Portfolio Managers

Wealth First Portfolio Managers Limited has informed stock exchanges about the issuance of new securities. This move typically involves the company raising capital by issuing fresh shares or convertible instruments to investors.

For investors, this development signals an attempt by the firm to bolster its financial resources. The infusion of capital can be used for business expansion, debt repayment, or funding new projects, which may impact the company's future growth prospects.

Investors should monitor the specific purpose of this fund raising and the current market conditions. It is important to assess whether the dilution of existing shares will be offset by the anticipated benefits of the capital infusion.